About Us
Elevion Pharma: Guiding your medicines from development to market with expert regulatory support.
About Elevion Pharma
Elevion Pharma is a UK‑based global leader in Human Medicines Regulatory Affairs. We partner with companies to accelerate approval strengthen compliance, and maximise commercial success through tailored, high‑impact regulatory strategies.
Our approach goes beyond traditional regulatory support. We deliver agile, innovative, and commercially aligned solutions that anticipate regulatory expectations and support your product’s strategic positioning. From early development to post‑approval lifecycle management, we ensure your submissions are robust, your licences are secured efficiently, and your products meet the highest standards of quality, efficacy, and safety.
Serving clients across the UK, EU, and MENA regions, we provide comprehensive regulatory, PV and compliance services that help you navigate complex global requirements and unlock new business opportunities.
Choose Elevion Pharma for forward‑thinking regulatory expertise that drives approvals, supports growth, and elevates your competitive advantage in the pharmaceutical industry.


Team Expertise
Our team brings together over three decades of combined experience across regulatory authorities, top global pharmaceutical companies, consumer healthcare organisations, pharma and digital transformation consultancies in the EU, UK and MENA regions. This diverse background enables us to support a wide spectrum of regulatory and strategic projects with precision, depth, and real‑world insight.


Regulatory Affairs Excellence Across UK, EU & Global Markets
The team has extensive hands‑on experience with:
MHRA,EMA and MENA
Marketing Authorisation Applications (MAAs)
Clinical Trial Applications (CTAs) and modifications
Paediatric Investigation Plans (PIPs), Scientific Advice and Pre-submission meetings
Lifecycle management - variations, renewals, and post‑approval activities
Orphan product and rare disease regulatory support – ODDs, EAMS and Compassionate use.
Product Information development (SmPC, PIL, CCDS, labelling, mock-ups)
Pre-vetting, aRMMs, promotional and non-promotional materials review.
The Windsor Framework and post-Brexit regulatory landscape
Innovative and generic products
This includes regulatory leadership for portfolios in Virology, Oncology, ATMPs, Rare Diseases, Anti-Infectives, Biologics, Sterile and Injectables, Endocrinology, Topical formulations, Consumer Healthcare, and Medical Devices, ensuring alignment with global development plans and regional requirements.
Experience Across Leading Organisations
Team members have contributed to regulatory strategy and execution within:
Global pharma leaders: Gilead, AstraZeneca, Pfizer, MSD, Alexion, Teva, Crescent Pharma
Consumer healthcare giants: GSK Consumer Healthcare
Regulatory authorities: MHRA
Digital transformation consultancies: Infosys
This breadth ensures familiarity with both authority-side expectations and industry-side delivery, enabling well‑rounded, practical guidance.
Digital Transformation & Regulatory Technology
The team also brings strong digital capability, including:
Veeva Vault RIM (advanced lifecycle workflows)
PROTON, CRM Dynamics
SQL, BI tools (Power BI, Tableau)
Process modelling and SDLC
Digital Twin architecture development
AI/GenAI applications for workflow optimisation
This combination of regulatory and digital expertise allows us to support modernisation initiatives, data-driven decision-making, and operational efficiency improvements.
Cross‑Functional & Strategic Leadership
Team members have represented Regulatory Affairs in:
Global project teams
Cross-functional development programmes
Strategic initiatives involving CMC, Clinical, Medical, Safety, Supply Chain, and Commercial teams
Diversity & inclusion programmes and organisational engagement groups
This ensures strong communication, stakeholder management, and the ability to navigate complex organisational environments.
What This Means for You
With this combined expertise, our team can confidently support:
Early development regulatory strategy
Clinical trial submissions and maintenance
Pre-MAA supply
EU/UK, MENA marketing authorisation pathways
Post‑approval lifecycle management
Labelling and compliance reviews
Regulatory intelligence and risk mitigation
Digital transformation of regulatory processes
Workflow optimisation and documentation excellence
Whether your query is scientific, strategic, operational, or digital, our team has the experience to provide informed, practical, and high‑quality support.
Elevion Pharma’s guidance made our regulatory process smooth and stress-free.
Dr. Lee
★★★★★
Contact Us
Reach out to Elevion Pharma for expert regulatory support tailored to your needs.
Elevion Pharma
Precision regulatory affairs and MHRA/EMA submission pathways.
Navigation
Home
Services
Strategy
Contact
Regulatory Advisory
info@elevionpharma.com
London
© 2026 Elevion Pharma-MHRA and EMA submission pathways engineered for life-changing therapies.
Audit-ready compliance
